The Medicaid Drug Rebate Program and Value-Based Purchasing
On March 23, 2022, the Centers for Medicare and Medicaid Services issued long-awaited guidance regarding how drug manufacturers are to report multiple best prices to the Medicaid Drug Rebate Program under value-based purchasing arrangements.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year